{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:12:33Z","timestamp":1780585953562,"version":"3.54.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"DOI":"10.1093\/jac\/dkp190","type":"journal-article","created":{"date-parts":[[2009,5,28]],"date-time":"2009-05-28T20:24:31Z","timestamp":1243542271000},"page":"411-415","source":"Crossref","is-referenced-by-count":12,"title":["Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial"],"prefix":"10.1093","volume":"64","author":[{"given":"C. M.","family":"Jespersen","sequence":"first","affiliation":[{"name":"The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark"},{"name":"Department of Cardiology Y, Bispebjerg Hospital, Copenhagen University Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Kolmos","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Frydendall","sequence":"additional","affiliation":[{"name":"The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hilden","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Institute of Public Health, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gluud","sequence":"additional","affiliation":[{"name":"The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fischer","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Cardiology Y, Bispebjerg Hospital, Copenhagen University Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CLARICOR Trial Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,5,28]]},"reference":[{"key":"key\n\t\t\t\t20180328162318_DKP190C1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000022705","article-title":"Intervention with clarithromycin in patients with stable coronary heart disease: the CLARICOR trial design","volume":"1","author":"Hansen","year":"2001","journal-title":"Heart Drug"},{"key":"key\n\t\t\t\t20180328162318_DKP190C2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000128994","article-title":"Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease","volume":"111","author":"Gluud","year":"2008","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t20180328162318_DKP190C3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","article-title":"Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial","volume":"332","author":"Jespersen","year":"2006","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328162318_DKP190C4","author":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","year":"1996","journal-title":"ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6(R1)"},{"key":"key\n\t\t\t\t20180328162318_DKP190C5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328162318_DKP190C6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328162318_DKP190C7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180328162318_DKP190C8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/000348949910800408","article-title":"Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group","volume":"108","author":"Clifford","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"key\n\t\t\t\t20180328162318_DKP190C9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1469-0691.2004.0906.x","article-title":"A randomised, double-blind, double-dummy comparative study of gatifloxacin with clarithromycin in the treatment of community-acquired pneumonia","volume":"10","author":"Lode","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180328162318_DKP190C10","author":"U.S. Food and Drug Administration","journal-title":"FDA Alert for Healthcare Professionals: Clarithromycin (in the CLARICOR Study)"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/64\/2\/411\/13759202\/dkp190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:50:42Z","timestamp":1522284642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/64\/2\/411\/715349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,28]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,5,28]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkp190","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,8]]},"published":{"date-parts":[[2009,5,28]]}}}